Long intergenic non-protein coding RNA 2183 (LINC02183)

Long intergenic non-protein coding RNA 2183 (LINC02183) is a member of the long intergenic non-coding RNA (lincRNA) family, which are autonomously transcribed RNA molecules at least 200 nucleotides in length that reside in intergenic regions and do not overlap with protein-coding genes[1][3]. LINC02183 is annotated as a non-protein coding RNA, meaning it does not encode a functional protein. Instead, like other lincRNAs, it is predicted to play roles in regulating the expression of nearby or functionally related genes, potentially impacting chromatin structure, RNA stability, and transcriptional activity. Although the broad lincRNA family is implicated in processes such as gene regulation, cell cycle control, and chromatin remodeling, as of now, there is no direct, experimentally validated evidence that LINC02183 serves as a therapeutic target, is involved in human disease, or is the direct target of any drug[1][3][5]. There are no established biomarkers, safety concerns, or mechanistic links to disease for LINC02183 specifically, and its biological functions have not yet been fully elucidated. Key context: - LINC02183 is primarily defined by its sequence and classification, rather than any known mechanism or therapeutic relevance[1]. - The lincRNA class at large may regulate gene expression, including chromatin state and enhancer-associated activity, but individual lincRNA genes are often poorly characterized unless specifically studied[3][5]. - There is no evidence in gene/protein-focused databases of this transcript being a drug target, disease biomarker, or being directly linked to specific pathologies as of the current literature[1]. If more detailed or functional information on LINC02183 specifically becomes available in the future, this entry should be updated accordingly.

Other names

LINC02183Long intergenic non-protein coding RNA 2183